Cost Plus Drugs began selling TheracosBio’s Brenzavvy (bexagliflozin), an FDA-approved Type 2 diabetes medication, on July 13, according to a news release. Its other branded drugs are IBSA Pharma’s Tirosint; Johnson & Johnson’s Invokana, Invokamet and Invokamet extended-release; and Pfizer’s Duavee, Estring, Premarin, Premphase and Prempro.
Mark Cuban Cost Plus Drugs adds 10th brand-name drug
Mark Cuban Cost Plus Drug Co. added its 10th brand-name drug to its portfolio that includes about 1,000 generics.
From Operations to Outcomes: How AI is Reshaping Healthcare RCM
Recommended Live Webinar on Jun 17, 2025 12:00 PM - 1:00 PM CDT